These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15349042)

  • 21. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC; Choi JS; Joo CK
    Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing trends in the treatment of dry-eye disease.
    Dogru M; Nakamura M; Shimazaki J; Tsubota K
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1581-601. PubMed ID: 24088227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
    Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
    Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.
    Bremond-Gignac D; Gicquel JJ; Chiambaretta F
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):905-13. PubMed ID: 24797483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavonoid and cannabinoid impact on the ocular surface.
    Bielory L; Tabliago NRA
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical correlations of dry eye syndrome and allergic conjunctivitis in Korean children.
    Kim TH; Moon NJ
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):124-7. PubMed ID: 23316947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels.
    Lin PH; Jian HJ; Li YJ; Huang YF; Anand A; Huang CC; Lin HJ; Lai JY
    Acta Biomater; 2022 Mar; 141():140-150. PubMed ID: 35081433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What's new in ocular surface disease?].
    Messmer EM; Benitez-Del-Castillo JM; Lambiase A; Doan S
    Ophthalmologe; 2005 Mar; 102(3):293-300. PubMed ID: 15616816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Ophthalmic Solutions on Tear Components.
    Shigeyasu C; Yamada M; Akune Y
    Cornea; 2016 Nov; 35 Suppl 1():S71-S77. PubMed ID: 27661071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye.
    Yang JM; Choi W; Kim N; Yoon KC
    Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiinflammatory therapy for dry eye.
    Pflugfelder SC
    Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.
    Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J
    Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
    Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dry eye syndrome, tear film, pharmacology of eye drops, and toxicity.
    van Setten GB
    Curr Opin Ophthalmol; 1997 Aug; 8(4):41-5. PubMed ID: 10170443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.